Linoleic acid and coronary heart disease

William Harris

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The extent to which higher intakes of linoleic acid (LA) affect risk for coronary heart disease (CHD) is examined by reviewing a wide variety of study types, mostly in humans. In experimental studies, LA has been shown to lower serum levels of low-density lipoprotein cholesterol (LDL-C), especially when substituted for saturated fatty acids. Such an effect would be expected to reduce risk for CHD. In observational studies in which the dietary intake or serum content of LA were either cross-sectionally or prospectively related risk for CHD, higher LA intakes or serum levels have usually been associated with reduced risk. The pooled results from 5 randomized trials where LA was substituted for saturated fatty acids revealed a significant decrease in risk for CHD events with an LA intake 2-3 times current levels. Thus, current recommendations to consume 5-10% of energy from LA are evidence-based, and should not be reduced.

Original languageEnglish (US)
Pages (from-to)169-171
Number of pages3
JournalProstaglandins Leukotrienes and Essential Fatty Acids
Volume79
Issue number3-5
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Linoleic Acid
Coronary Disease
Fatty Acids
Serum
LDL Cholesterol
Observational Studies

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry

Cite this

Linoleic acid and coronary heart disease. / Harris, William.

In: Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 79, No. 3-5, 09.2008, p. 169-171.

Research output: Contribution to journalArticle

Harris, William. / Linoleic acid and coronary heart disease. In: Prostaglandins Leukotrienes and Essential Fatty Acids. 2008 ; Vol. 79, No. 3-5. pp. 169-171.
@article{7cf792fd223449ceaaf8f565b17add91,
title = "Linoleic acid and coronary heart disease",
abstract = "The extent to which higher intakes of linoleic acid (LA) affect risk for coronary heart disease (CHD) is examined by reviewing a wide variety of study types, mostly in humans. In experimental studies, LA has been shown to lower serum levels of low-density lipoprotein cholesterol (LDL-C), especially when substituted for saturated fatty acids. Such an effect would be expected to reduce risk for CHD. In observational studies in which the dietary intake or serum content of LA were either cross-sectionally or prospectively related risk for CHD, higher LA intakes or serum levels have usually been associated with reduced risk. The pooled results from 5 randomized trials where LA was substituted for saturated fatty acids revealed a significant decrease in risk for CHD events with an LA intake 2-3 times current levels. Thus, current recommendations to consume 5-10{\%} of energy from LA are evidence-based, and should not be reduced.",
author = "William Harris",
year = "2008",
month = "9",
doi = "10.1016/j.plefa.2008.09.005",
language = "English (US)",
volume = "79",
pages = "169--171",
journal = "Prostaglandins Leukotrienes and Essential Fatty Acids",
issn = "0952-3278",
publisher = "Churchill Livingstone",
number = "3-5",

}

TY - JOUR

T1 - Linoleic acid and coronary heart disease

AU - Harris, William

PY - 2008/9

Y1 - 2008/9

N2 - The extent to which higher intakes of linoleic acid (LA) affect risk for coronary heart disease (CHD) is examined by reviewing a wide variety of study types, mostly in humans. In experimental studies, LA has been shown to lower serum levels of low-density lipoprotein cholesterol (LDL-C), especially when substituted for saturated fatty acids. Such an effect would be expected to reduce risk for CHD. In observational studies in which the dietary intake or serum content of LA were either cross-sectionally or prospectively related risk for CHD, higher LA intakes or serum levels have usually been associated with reduced risk. The pooled results from 5 randomized trials where LA was substituted for saturated fatty acids revealed a significant decrease in risk for CHD events with an LA intake 2-3 times current levels. Thus, current recommendations to consume 5-10% of energy from LA are evidence-based, and should not be reduced.

AB - The extent to which higher intakes of linoleic acid (LA) affect risk for coronary heart disease (CHD) is examined by reviewing a wide variety of study types, mostly in humans. In experimental studies, LA has been shown to lower serum levels of low-density lipoprotein cholesterol (LDL-C), especially when substituted for saturated fatty acids. Such an effect would be expected to reduce risk for CHD. In observational studies in which the dietary intake or serum content of LA were either cross-sectionally or prospectively related risk for CHD, higher LA intakes or serum levels have usually been associated with reduced risk. The pooled results from 5 randomized trials where LA was substituted for saturated fatty acids revealed a significant decrease in risk for CHD events with an LA intake 2-3 times current levels. Thus, current recommendations to consume 5-10% of energy from LA are evidence-based, and should not be reduced.

UR - http://www.scopus.com/inward/record.url?scp=56449089481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56449089481&partnerID=8YFLogxK

U2 - 10.1016/j.plefa.2008.09.005

DO - 10.1016/j.plefa.2008.09.005

M3 - Article

C2 - 18951772

AN - SCOPUS:56449089481

VL - 79

SP - 169

EP - 171

JO - Prostaglandins Leukotrienes and Essential Fatty Acids

JF - Prostaglandins Leukotrienes and Essential Fatty Acids

SN - 0952-3278

IS - 3-5

ER -